Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
311.00    9.00 (2.98%)
Bid:
306.00
Ask:
310.00
Spread: 4.00 (1.307%)
Market Cap: £279.55m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Directors Dealing

27 Jul 2016 17:21

RNS Number : 4421F
Norcros PLC
27 July 2016
 

27 July 2016

Norcros plc

("Norcros" or "the Company")

 

 Directors' Dealings - APSP Share Option and Deferred Share awards

 APSP Share Option Awards

Norcros announces that the Remuneration Committee of the Company has today granted the following HMRC approved and unapproved share option awards (the "APSP Awards") to the Executive Directors of the Company under the Company's Approved Performance Share Plan (the "APSP") over ordinary shares of ten pence each in the Company ("Ordinary Shares").

Name/Position

Number of Ordinary Shares subject to the APSP Award

Option Exercise Price

Nick Kelsall

Group Chief Executive

232,356 (HMRC unapproved)

Nil

Shaun Smith

Group Finance Director

20,000 (HMRC approved)

150 pence

Shaun Smith

Group Finance Director

136,060 (HMRC unapproved)

Nil

 

Under the APSP, awards are made subject to performance targets relating to the Company's diluted underlying Earnings Per Share ("EPS"). Vesting of these shares is subject to achieving aggregate EPS over a three year performance period, starting with the 2017 financial year.

The APSP Awards will normally vest on the third anniversary of their grant, subject to satisfactory achievement of the performance targets. No consideration was paid for the APSP Awards and the consideration due to be payable on vesting will be the option exercise price (if any) shown above.

Bonus payment - Deferred Share Awards

Under the annual bonus scheme, 50 per cent. of an Executive Director's total bonus for the year is satisfied in cash, with the other 50 per cent. in the form of nil cost options under the Company's Deferred Share Bonus Plan (the "Deferred Plan"). These options represent 50 per cent. of the bonuses earned by the Executive Directors for the 2016 financial year. The previous Group Finance Director's entitlement to this award lapsed on his resignation, effective 12 May 2016.

Norcros therefore also announces that the Remuneration Committee has today granted the following nil cost share option awards in respect of the year ended 31 March 2016 (the "Deferred Awards") to the relevant Executive Director of the Company over ordinary shares of ten pence each in the Company ("Ordinary Shares").

Name/Position

Number of Ordinary Shares subject to the Deferred Plan Award

Nick Kelsall

Group Chief Executive

92,544

 

The Deferred Awards will normally vest on the third anniversary of their grant. Because these shares represent part of a bonus already earned, no consideration was paid for the Deferred Awards and no consideration is due to be payable on vesting.

Other information:

Norcros plc LEI: 213800EIMJZZA1GB1E18

Ordinary Shares identity code: GB00BYYJL418

Date of transaction: 27 July 2016

Place of transaction: Wilmslow, Cheshire, England

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Group Chief Executive

Shaun Smith, Group Finance Director

 

 

 

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

 

Charlie Jack

 

Katie Cohen

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGURAMUPQGAM
Date   Source Headline
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results
1st Nov 202212:07 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
30th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20227:00 amRNSVoting Rights and Share Capital Update
13th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20229:39 amRNSVoting Rights and Share Capital Update
26th Jul 202212:30 pmRNSHolding(s) in Company
25th Jul 20222:23 pmRNSDirectors' Dealings
19th Jul 20222:05 pmRNSResults of AGM
19th Jul 20221:57 pmRNSDirector Dealings
19th Jul 20227:00 amRNSAGM Trading Statement
15th Jul 20225:08 pmRNSVoting Rights and Share Capital Update
30th Jun 20229:08 amRNSVoting Rights and Share Capital Update
21st Jun 20225:21 pmRNSDirector Declaration
16th Jun 202211:16 amRNSNotice of AGM Annual Report Announcement
14th Jun 20222:25 pmRNSHoldings in Company
9th Jun 20227:00 amRNSFinal Results
31st May 20221:01 pmRNSCompletion of Acquisition of Grant Westfield
31st May 20227:00 amRNSVoting Rights and Share Capital Update
30th May 202211:07 amRNSResult of General Meeting
16th May 20222:19 pmRNSHolding(s) in Company
12th May 202212:08 pmRNSPublication and Posting of Circular
12th May 20227:00 amRNSResults of Placing
11th May 20224:41 pmRNSProposed Placing
11th May 20224:41 pmRNSProposed Acquisition of Grant Westfield
29th Apr 20224:53 pmRNSTotal Voting Rights
26th Apr 20225:16 pmRNSHolding(s) in Company
25th Apr 20225:50 pmRNSHolding(s) in Company
21st Apr 20223:01 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update
8th Apr 20223:40 pmRNSHolding(s) in Company
31st Mar 20225:16 pmRNSTotal Voting Rights and Share Capital Update
18th Mar 202211:15 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSSenior Management Appointment
20th Jan 20221:37 pmRNSRemuneration Resolution Vote - AGM 2021
8th Dec 20217:00 amRNSDirectorate Changes
11th Nov 20217:00 amRNSInterim Results
1st Nov 20219:16 amRNSTotal Voting Rights
14th Oct 20217:00 amRNSTrading Update
30th Sep 20217:05 amRNSTotal Voting Rights
30th Sep 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Sep 20213:37 pmRNSHolding(s) in Company
31st Aug 202110:46 amRNSTotal Voting Rights
27th Aug 20214:59 pmRNSHolding(s) in Company
2nd Aug 20217:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSSenior Management Appointments
27th Jul 20215:35 pmRNSDirectors' Dealings
21st Jul 20213:03 pmRNSDirector Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.